Ongoing research and investigational therapies, such as GIP/GLP-1/glucagon triple agonists, may inform future strategies for sustainable weight loss after discontinuation of weight loss pharmacotherapy
If you have two hands and can do it, you can stabilize the needle with one hand or you can just move your finger back and push all the medication in at a slow, steady rate
A lot of clinicians think they do, but he is not persuaded
Another recent survey by Accolade trusted partner Virta confirmed that high-costs of GLP-1s, driven by an anticipated rise in utilization, are a concern for a majority (72%) of health plan leaders
This puts GLP-1 patients at high dehydration risk, which worsens headaches, fatigue, and constipation already common side effects